Back to All

Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks

5 December, 2024

Amplifying Your Precision Medicine Strategy: The Role of Engagement Experts and Peer Networks

How can multi-modal communications and peer-to-peer engagement elevate your diagnostic commercialization strategy? 

In this Q&A, we share insights on how these approaches can amplify your precision medicine strategy, enhance diagnostic commercialization, and ensure your message effectively reaches the right audience.


Q1 How does incorporating multi-modal communications enhance your diagnostic commercialization strategy?

By utilizing different modes of communication and by leveraging the available messengers i.e. the pathologists, your precision medicine story is maximized and amplified driving overall brand success.


Q2 How would access to our Precision Medicine Engagement Experts increase your team's ability to deliver messaging about the importance of testing?

Tapping into the right message is critical for marketing success. Utilizing the right messenger is equally important. Our Precision Medicine Engagement Experts have spent decades in the laboratory. They speak the language and have the battle scars consistent with your audience giving them a unique perspective and unique skills to deliver messaging on your biomarker needs, from a laboratorians perspective.


Q3  Why is stakeholder engagement at a peer to peer level  crucial for the success of precision medicine testing?

Addresses a known practice gap, brings confidence, Collaborative and more efficient working at tumor boards to ensure a patient get access to the best therapy options. Raising your engagements to a peer-to-peer level delivers a heightened degree of importance. This model increase access and delivers your content at the level of your audience, practicing physician to practicing physician.

Q4 What advantages does our DXRX Expert Exchange solution offer in expanding and promoting test awareness?

Biomarker testing does not occur in a vacuum. There are a number of additional factors that HCPs deal with long after your field teams leave the office. When your message is delivered by someone who deals with the same challenges day in and day out, there is a level of understanding and acceptance that occurs that otherwise is missed in a standard field engagement. Expert Exchange adds significant weight to your biomarker messaging.

Discover more in our next webinar in The Precision Medicine series, “Accelerate precision medicine uptake with impactful scientific engagement” on December 12th, 1-2pm EST/7-8pm CET. Ken Ruppel, VP, Scientific & Medical Services, will demonstrate how impactful scientific engagement can enhance the clinical utility of precision medicine. Understand the nuances of your biomarker as it launches into the open market and discover strategies to remove barriers and maximize patient identification.

Register for webinar here: https://lnkd.in/ep--Jn6f



About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny